Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that Steven Perrin, Ph.D., President and Chief Scientific Officer will participate in a fireside chat at the upcoming Guggenheim ...
Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United ...
A new generation of engineered immune cell destroys cancer cells in mice 1 as effectively as conventional CAR-T-cell ...
Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic ...
MedPage Today on MSN
CMS makes push to maximize donor organs, even the imperfect ones
Agency aims to increase federal oversight amid reports of "unsafe practices" ...
The EPITA Symposium brings together global scientists, clinicians, and industry leaders to advance biological therapies for diabetes, including islet transplantation and beta cell replacement. EPITA ...
Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders, today announced ...
A recent study by Vanderbilt Health researchers has revealed a greater, detrimental role for B lymphocytes (B cells) in the progression of type 1 diabetes (T1D).
3 Guy’s and St Thomas’ NHS Foundation Trust, London, UK 4 King’s College Hospital NHS Foundation Trust, London, UK Background Autologous haematopoietic stem cell transplantation (AHSCT) is ...
Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results